Phospho-IGF-I Receptor beta (Tyr1131)/Insulin Receptor beta (Tyr1146) (D6D5L) Rabbit mAb (BSA and Azide Free)

Type I insulin-like growth factor receptor (IGF-IR) is a transmembrane receptor tyrosine kinase that is widely expressed in many cell lines and cell types within fetal and postnatal tissues (1-3). Receptor autophosphorylation follows binding of the IGF-I and IGF-II ligands. Three tyrosine residues within the kinase domain (Tyr1131, Tyr1135, and Tyr1136) are the earliest major autophosphorylation sites (4). Phosphorylation of these three tyrosine residues is necessary for kinase activation (5,6). Insulin receptors (IRs) share significant structural and functional similarity with IGF-I receptors, including the presence of an equivalent tyrosine cluster (Tyr1146/1150/1151) within the kinase domain activation loop. Tyrosine autophosphorylation of IRs is one of the earliest cellular responses to insulin stimulation (7). Autophosphorylation begins with phosphorylation at Tyr1146 and either Tyr1150 or Tyr1151, while full kinase activation requires triple tyrosine phosphorylation (8). 1.Adams, T.E. et al. (2000) Cell Mol Life Sci 57, 1050-93. 2.Baserga, R. (2000) Oncogene 19, 5574-81. 3.Scheidegger, K.J. et al. (2000) J Biol Chem 275, 38921-8. 4.Hernández-Sánchez, C. et al. (1995) J Biol Chem 270, 29176-81. 5.Lopaczynski, W. et al. (2000) Biochem Biophys Res Commun 279, 955-60. 6.Baserga, R. (1999) Exp Cell Res 253, 1-6. 7.White, M.F. et al. (1985) J Biol Chem 260, 9470-8. 8.White, M.F. et al. (1988) J Biol Chem 263, 2969-80.